Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvirin Safety and Immunogenicity in Healthy Adults
NCT01885117Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2013
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Influenza A virus hemagglutinin antigen (A/Uruguay/716/2007 H3N2) in influenza, sponsored by Novartis. Started Aug 2013; status: completed.
02
Drugs
Influenza A virus hemagglutinin antigen (A/Uruguay/716/2007 H3N2)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01885117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01885117.